MedTrace Logo

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.

NCT06344650 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-08-22

No results posted yet for this study

Summary

Prospective observational clinical, molecular, translational study aimed at identifying the main determinants and predictive factors of fragility fracture risck in acromegaly patients

Conditions

Interventions

PROCEDURE

Blood sample

Collection of blood serum for molecular and biochemical tests

DIAGNOSTIC_TEST

Radiological tests

Performance of radiological tests (DXA, VFA, TBS, BSi, HR-pQCT) and DXA morphometry

OTHER

Questionnaires

Compilation of questionnaires (AcroQol, SF-36)

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Campus Bio-Medico

    collaborator OTHER

  • Istituto Auxologico Italiano

    collaborator OTHER

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2024-10-31
Completion
2026-04-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06344650 on ClinicalTrials.gov